The stresses of the pandemic were many. But where there were struggles, there was innovation.
While there were failures in the health care industry — namely in supply and infrastructure — there were triumphant successes as medical elastomer companies stepped up personal protective equipment production and pharmaceutical companies produced effective vaccines.
Looking ahead, mergers and acquisitions are expected to increase, which will drive research and development spending — perhaps even toward artificial intelligence and mechanical learning.
Demand for medical elastomers will continue to increase, with some estimating an annual growth rate of 6 percent for thermoplastics and synthetic elastomers.
There are reasons for optimism post-COVID-19. A better-prepared health care industry — through telehealth and a better recognition of mental health — is are major ones.